NYSE American - Nasdaq Real Time Price USD
Impact BioMedical Inc. (IBO)
0.4197
+0.0171
+(4.25%)
At close: April 21 at 3:59:30 PM EDT
0.4101
-0.01
(-2.29%)
After hours: April 21 at 7:57:34 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| CHAN HENG FAI AMBROSE Director and Beneficial Owner of more than 10% of a Class of Security | Sale | Apr 4, 2025 | -- |
| DSS INC. Beneficial Owner of more than 10% of a Class of Security | Sale | Apr 4, 2025 | 1,339,980 |
| HEUSZEL FRANK D. Chief Executive Officer | Purchase | Dec 5, 2024 | 97,344 |
Related Tickers
PSTV Plus Therapeutics, Inc.
0.6410
-2.67%
CDT Conduit Pharmaceuticals Inc.
0.5482
-11.59%
OSRH OSR Holdings, Inc.
1.3300
0.00%
PHIO Phio Pharmaceuticals Corp.
2.8300
+3.66%
KTTA Pasithea Therapeutics Corp.
1.4300
+3.62%
PCSA Processa Pharmaceuticals, Inc.
0.2200
0.00%
HEPA Hepion Pharmaceuticals, Inc.
0.2700
-16.18%
MTVA MetaVia Inc.
0.7326
-0.87%
QNRX Quoin Pharmaceuticals, Ltd.
5.67
+2.90%
CHRO Channel Therapeutics Corporation
1.4300
-22.28%